Dexcom Inc (DXCM) is overvalued and Koninklijke Philips NV ADR (PHG) is overvalued.
Both trade above our estimate of their intrinsic value. PHG is the closer of the two: -37%, against -61% for DXCM.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 11.4% (average of 3 methods) values the shares at $55.75; the price of $89.53 is 61% above that value, and 70% of that value comes from beyond year five.
Leak Score 68/100 on 9 of 12 signals
Discounting its cash flows at 8.1% (average of 3 methods) values the shares at $18.23; the price of $24.97 is 37% above that value, and 79% of that value comes from beyond year five.
Leak Score 27/100 on 3 of 12 signals
| Metric | DXCM | PHG |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Price | $89.53 | $24.97 |
| Intrinsic value | $55.75 | $18.23 |
| Margin of safety | -61% | -37% |
| Leak Score | 68/100 (9/12) | 27/100 (3/12) |
| Market cap | $33.8B | $24.4B |
| Revenue growth, 5 years | 19.3% | 0.4% |
| Operating margin | 22.9% | 9.1% |
| Net margin | 20.1% | 6.3% |
| Return on equity | 38.5% | 10.2% |
| Debt to equity | 0.53 | 0.65 |
| P/E | 35.3x | 18.6x |
| Forward P/E | 28.7x | 13.1x |
| P/B | 12.9x | 1.9x |
| Dividend yield | — | 4.0% |